PKM and lung cancer: In addition, Wang et al. have reported that hiTDExs directly led to cisplatin resistance in lung cancer increasing glycolysis or by transferring Pyruvate Kinase (PKM2) to tumor cell mitochondria and also indirectly reorchestrated CAFs to change the pH value of the micro-milieu.